Conformis, Inc.
Conformis, Inc., a pioneering force in the orthopaedic industry, is headquartered in the United States and operates across key regions globally. Founded in 2004, the company has established itself as a leader in personalised joint replacement solutions, focusing primarily on knee and hip implants. Conformis is renowned for its innovative approach, offering customised implants that are tailored to the unique anatomy of each patient, setting it apart from traditional off-the-shelf products. This bespoke methodology not only enhances surgical outcomes but also improves patient satisfaction. With a strong market position, Conformis has achieved significant milestones, including numerous FDA approvals and a growing portfolio of patented technologies. The company continues to redefine the standards of care in orthopaedics, making strides in both product development and patient-centric solutions.
DitchCarbon Score
How does Conformis, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Conformis, Inc.'s score of 18 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Conformis, Inc.'s reported carbon emissions
Conformis, Inc., headquartered in the US, currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Conformis may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As the company operates within the medical device industry, it is essential for Conformis to consider implementing robust climate strategies to align with growing environmental expectations and regulatory pressures. Without specific emissions data or reduction initiatives, it remains unclear how Conformis plans to address its environmental impact moving forward.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Conformis, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
